At AstaReal, sustainability is not just a goal—it’s woven into our identity and heritage. From the very beginning, our work with Haematococcus pluvialis, the microalga behind our natural astaxanthin, has connected us to the very foundations of life. Microalgae are essential to aquatic ecosystems and have nourished humanity for millennia. Today, we proudly carry that legacy forward by offering a natural product that promotes health and wellbeing worldwide. 

As we close the books on FY2024, we do so with a deeper understanding of our environmental and social impact than ever before. This past year has been one of meaningful progress and thoughtful reflection. While we celebrate our achievements, we remain humbled by the responsibility we carry—and more determined than ever to pursue continuous improvement and responsible growth. 

We expanded our consumer portfolio with the launch of Astaxin Stockholm, our premium skincare line, and welcomed health-focused brands like Kyolic and Medcoat into the AstaReal family. These additions strengthen our mission to support public health through science-backed, natural solutions. 

With over 75 human clinical studies, AstaReal® remains the most researched brand of natural astaxanthin on the market—underscoring our commitment to scientific rigor and evidence-based innovation. Our recent research into digital eye strain in children has yielded promising results, further highlighting the potential of natural astaxanthin to enhance quality of life. 

Operationally, we’ve made significant strides in reducing our environmental footprint per product through production upgrades and cultivation optimisation. Completing our first double materiality assessment marked a key milestone in aligning our sustainability strategy with stakeholder expectations and financial relevance. Our climate reporting has also matured, with broader Scope 3 data coverage and a more integrated approach across our value chain. 

None of this would be possible without the dedication and collaborative spirit of our global team—from our production site in Gustavsberg to our newly established subsidiary in Shanghai. We are united by a shared purpose: to contribute to better health and wellbeing—for individuals, communities, and future generations. 

As we look ahead, we remain committed to transparency, continuous progress, and creating meaningful impact. I invite you to explore this report and join us on our journey toward a healthier planet—and a healthier you. 

Thank you for your continued support. 

Daniel Flodqvist
CEO AstaReal AB